Efficacy of rituximab in dermatomyositis and polymyositis refractory to conventional therapy.
We report one case of dermatomyositis and one of polymyositis refractory to several conventional inmunosupressive therapies, which present a response after treatment with rituximab, enabling steroid dose reduction and a prolonged remission.